Category: us corporate news

us corporate news

Corebridge Financial, Inc. Files Form 8-K with SEC for Common Stock and 6.375% Junior Subordinated Notes Listing on NYSE

Minichart

March 24, 2026

Corebridge Financial, Inc. Files Form 8-K: Key Shareholder a...

Continue Reading 0

us corporate news

WisdomTree Prices $603.75 Million Convertible Senior Notes Offering to Fund Acquisition and Exchange Existing Debt

Minichart

March 24, 2026

WisdomTree Announces Major Convertible Notes Offering, Acqui...

Continue Reading 0

us corporate news

Rezolute Updates on Congenital Hyperinsulinism Program After FDA Meeting; SunRIZE Data Under Review for Potential Advancement 1

Minichart

March 24, 2026

Rezolute, Inc. Provides Update on Congenital Hyperinsulinism...

Continue Reading 0

us corporate news

Compass Pathways Announces 2025 Financial Results and Highlights Progress Toward FDA Approval of COMP360 for Treatment-Resistant Depression

Minichart

March 24, 2026

COMPASS Pathways Reports Full-Year 2025 Financial Results an...

Continue Reading 0

us corporate news

Core & Main Reports Fiscal 2025 Q4 and Full-Year Results: Market Share Gains, Margin Expansion, and Strategic Growth Initiatives 6921

Minichart

March 24, 2026

Core & Main, Inc. Announces Fiscal 2025 Fourth Quarter and F...

Continue Reading 0

us corporate news

Neurogene Reports Positive Interim Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome and Advances Toward Commercialization in 2026

Minichart

March 24, 2026

Neurogene Inc. 2025 Full Year Results & Corporate Update ...

Continue Reading 0

us corporate news

Concentrix Reports Q1 2026 Results: Revenue Grows 5.4%, Maintains Strong Full-Year Outlook and iX Suite Momentum

Minichart

March 24, 2026

Concentrix Reports Q1 2026 Results: In-Depth Investor Summar...

Continue Reading 0

us corporate news

Hour Loop Reports 2025 Financial Results: Achieves Profit Growth and Strong Cash Flow Amid Challenging Retail Environment

Minichart

March 24, 2026

Hour Loop, Inc. Reports Full Year 2025 Financial Results: St...

Continue Reading 0

us corporate news

Smithfield Foods Reports Record Fiscal 2025 Results: Strong Sales Growth and Operating Profit Highlights

Minichart

March 24, 2026

Smithfield Foods Reports Record FY2025 Results and Issues Bu...

Continue Reading 0

us corporate news

Karyopharm’s Phase 3 SENTRY Trial Shows Significant Spleen Reduction and Promising Overall Survival in Myelofibrosis with Selinexor Plus Ruxolitinib 1

Minichart

March 24, 2026

Karyopharm Therapeutics Inc. - Detailed Investor Report on S...

Continue Reading 0